Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflammatory conditions and infrequent disorders. Founded in 2017, the company extends its market reach throughout the United States and into global territories, headquartered in Princeton, New Jersey.
| Price | $2.03 |
|---|---|
| Market cap | $14.25M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Exchange | NASDAQ |
| 52-week range | 1.75-6.63 |
| Beta | 1.51 |
Explore HIND's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.